Elon Musk’s brain-computer interface (BCI) start-up Neuralink has begun recruiting people for its first human trial.
The company’s goal is to connect human brains to computers and it wants to test its technology on people with paralysis.
A robot will help implant a BCI that will let them control a computer cursor, or type, using thoughts alone.
But rival companies have already implanted BCI devices in humans.
Neuralink won US Food and Drug Administration (FDA) approval for its first human clinical trial, in May, a critical milestone after earlier struggles to gain approval.
The FDA approval represented “an important first step that will one day allow our technology to help many people”, Neuralink said at the time
The company had sought approval to implant its devices in 10 people, former and current employees told news agency Reuters.
The number finally agreed upon is not known.